TAKE NSE filing

Take Solutions enters India's Longevity and Anti-Aging market

The RealCase readMedium impact Positive

Take Solutions is entering India's longevity and anti-aging market with science-backed nutraceuticals and digital wellness solutions. The company aims to leverage its healthcare expertise to tap into a growing market, projected to reach USD 67.03 billion by 2035 globally. This strategic move aligns with India's expanding preventive healthcare sector.

Why it matters

The announcement signifies a new business direction and market entry, which could have a moderate impact on the company's future revenue streams and market position.

The market read

The company's strategic entry into a growing market with a clear plan and stated expertise indicates a positive outlook and potential for future growth.

Take Solutions Limited has announced its strategic entry into the longevity and anti-aging market in India. The company plans to leverage its expertise in clinical research, life sciences, and regulatory processes to develop a scalable platform for consumer health products and digital wellness solutions.

The global longevity market, valued at USD 27.61 billion in 2025, is projected to reach USD 67.03 billion by 2035. In India, the opportunity spans anti-aging supplements, services, and preventive healthcare, driven by increasing consumer awareness and a growing burden of lifestyle diseases.

Take Solutions' strategy involves a dual model combining product innovation and technology-enabled health solutions. This includes developing science-backed nutraceuticals, biohacking products, and predictive digital tools to help consumers track and optimize health metrics. The company aims to build a diversified revenue stream across consumer products, services, and digital platforms.

Mr. Parmeshvar Dhangare, Director of Take Solutions Limited, stated, "Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible."

India's preventive healthcare market was valued at USD 197 billion by 2025. The Indian anti-aging supplements market is projected to grow to USD 341.4 million by 2033, and the anti-aging services market was valued at USD 567.5 million in 2024. Take Solutions believes its existing capabilities in healthcare operations, regulatory support, and life sciences will accelerate development and commercialization in this segment.

Filing to action

What to do with a filing like this

Take Solutions Limited filed this with the NSE as a statutory disclosure, categorised under other company updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Take Solutions Limited. Read the original for the full detail.

View original filing